Roche Pharma India has launched a subcutaneous Tecentriq injection for eligible lung cancer patients. The shorter dosing time ...

Approved by the Drugs Controller General of India around two months ago for adjuvant and metastatic non-small cell lung cancer, Tecentriq SC is now available across India with more than 100 patients ...

While tobacco use remains one of the leading causes, there is growing evidence that environmental and genetic factors are ...

Cancer patients and their caretakers in India often spend long, arduous hours in hospitals for conventional treatment.But now with the launch of the ...

Roche launched Tecentriq SC in India, reducing lung cancer immunotherapy delivery time from hours to just seven minutes.

If cigarettes aren’t the culprit, what is? Scientists and doctors point to three distinct, overlapping environmental and ...

BENGALURU: Ahead of World No Tobacco Day on May 31, cancer specialists warned about the growing and under reported burden of ...

A 74-year-old Uttarakhand man, deemed too high-risk for lung cancer surgery due to severe breathing issues and diabetes, has successfully undergone robotic surgery at Apollo Hospitals. A comprehensive ...

For many lung cancer patients in India, treatment is not only about the drug. It is also about the day built around it: the ...

Public health experts report a worrying rise in lung cancer cases among non-smokers, especially women, across southern India. Studies point to environmental pollution, household exposure and genetic ...